Cangrelor in addition to standard therapy reduces cardiac damage and inflammatory markers in patients with ST-segment elevation myocardial infarctionMohamed Abo‐Aly, Khaled M. Ziada, Elica Shokri et al.|Journal of Thrombosis and Thrombolysis|2020Cited by 11